Cowen And Company, LLC Omeros Corp Transaction History

Cowen And Company, LLC

  • $3.88 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$5.67 - $8.54 $46,856 - $70,574
-8,264 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$13.4 - $16.3 $375,119 - $456,302
-27,994 Reduced 77.21%
8,264 $114,000
Q2 2021

Aug 13, 2021
BUY
$14.81 - $19.13 $225,452 - $291,215
15,223 Added 72.37%
36,258 $538,000
Q1 2021

May 04, 2021
BUY
$14.52 - $23.53 $305,428 - $494,953
21,035 New
21,035 $374,000

Others Institutions Holding OMER

# of Institutions
121
Shares Held
25.6M
Call Options Held
228K
Put Options Held
630K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $555M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email